CTLA4 and neoplasm: On combination treatment with anti-CTLA4 (Ipilimumab), besides depletion of Treg and lowering of IL10 release, the spatial dynamics between CTL and Treg affected the incremental efficacy in tumor killing on combination treatment correlated with significant increase in distance between CTL and Treg (Fig. 8C).